Posts by Sandra Ansanay-Alex
Comphya Receives FDA IDE Approval to Initiate U.S. Clinical Trial for CaverSTIM
Comphya SA, a pioneering medical technology company based in canton of Vaud and the developer of CaverSTIM, the first implantable neuromodulator designed to treat erectile dysfunction, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a clinical trial to evaluate CaverSTIM in the United States. …
Read MoreHelix Robotics receives CHF 150,000 from Venture Kick
Helix Robotics is developing the first commercial soft robot manipulator. By combining the safety of soft robotics with industrial precision, the EPFL spin-off aims to enhance automation in food handling and lab automation. The startup was financed with CHF 150,000 by Venture Kick, winning the third stage of the programme. Traditional robotic arms…
Read MoreGARDP supports the development of Debiopharm’s new potential treatment for gonorrhoea
The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a novel compound representing a new antibiotic class that targets Neisseria gonorrhoeae. Multidrug-resistant strains of N. gonorrhoeae have emerged globally, limiting treatment options and elevating this pathogen to…
Read MoreJuvion Health Sciences and Neuria supported by the FIT
FIT announces the granting of two Tech Seed loans worth CHF 100,000 each to two Swiss Health Valley start-ups: Juvion Health Sciences and Neuria. Juvion: maintaining the structure and function of movement circuits to improve mobility One in three people over the age of 60 is affected by reduced mobility. This decline in…
Read MoreAspivix raises 1.95 million euros via crowdfunding campaign
Aspivix, the Swiss start-up behind Carevix™, an innovative device designed to transform gynecological practices, recently launched a crowdfunding campaign that has already raised 1.9 million euros. The initiative aims to bring together a community committed to supporting a technology focused on women’s comfort and health. With 85 investors, the crowdfunding campaign, accessible on…
Read MoreDiverSsiTy SA: Therapy for Adolescents with Autism Spectrum Disorder (ASD)
DiverSsiTy SA leverages Mixed Reality (MR) and Artificial Intelligence (AI) to revolutionise mental health for people with Autism Spectrum Disorder (ASD). The company has developed a personalized therapeutic solution designed to enhance social, emotional, and proprioceptive skills in adolescents with high-functioning autism, ultimately improving their quality of life and social integration. Origins &…
Read MoreA CHF 2 Million Innosuisse Grant for Tune Insight
2025 is off to a groundbreaking start for Tune Insight, a leading EPFL spin-off specializing in privacy-preserving data collaboration solutions. The start-up secured a CHF 2 Million Innosuisse Grant to revolutionise Real-World Evidence (RWE) access for AI in pharma. Despite growing interest in using Real-World Evidence (RWE) to fuel AI innovation in healthcare, access…
Read MoreVandria starts clinical trials for VNA-318
Vandria SA, a Vaud-based start-up at the vanguard of mitochondrial therapeutics developing first-in-class small molecule mitophagy inducers, announced last December that the first subjects have been dosed in its first-in-human clinical trial of its lead Central Nervous System (CNS) compound VNA-318. Readout of this combined single and multiple ascending dose trial is expected in the…
Read MoreAstrocyte and MyoLink supported by FIF
Two Geneva-based life sciences projects have been selected to receive funding through the FONGIT Innovation Fund (FIF). Astrocyte and MyoLink, received a grant and a Seed Loan. MyoLink: Simplifying muscle monitoring for gait rehabilitation MyoLink is addressing unmet needs in gait rehabilitation with a non-invasive, easy-to-set-up system for real-time muscle monitoring. Current tools…
Read MoreNeuria obtains final Kick of CHF 150,000
The UNIFR spin-off created a digital health solution targeting overweight through neuroscience and is supported by Venture Kick. More than 2 billion adults worldwide suffer from overweight and associated chronic diseases, such as obesity and diabetes. This public health problem is compounded by the failure of 80% of traditional interventions. Neuria, a health technology…
Read More